Erratum: Aβ peptide immunization restores blood-brain barrier integrity in Alzheimer disease (FASEB Journal (2006) 20 (426-433) DOI: 10.1096/fj.05-3956com);Aβ peptide immunization restores blood-brain barrier integrity in Alzheimer disease

FASEB Journal

Volumn 20, Issue 3, 2006, Pages 426-433

  Dickstein, Dara L ^a,b   Biron, Kaan E ^a,b   Ujiie, Maki ^a,b   Pfeifer, Cheryl G ^a,b   Jeffries, Andrew R ^a,b   Jefferies, Wilfred A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain; Microcirculation; Plaques; Vaccination

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN; ANTIBODY; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MALE; MICROGLIA; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; DISEASE MODEL; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SENILE PLAQUE; TRANSGENIC MOUSE; VACCINATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; SENILE PLAQUES; VACCINATION;

EID: 33645816954     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-3956com     Document Type: Erratum

References (50)

1. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (London) 400, 173-177
2. DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J. C., Paul, S. M., and Holtzman, D. M. (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 8850-8855
3. Mohajeri, M. H., Saini, K., Schultz, J. G., Wollmer, M. A., Hock, C., and Nitsch, R. M. (2002) Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation. J. Biol. Chem. 277, 33012-33017
4. Lemere, C. A., Spooner, E. T., Leverone, J. F., Mori, C., Iglesias, M., Bloom, J. K., and Seabrook, T. J. (2003) Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice. Neurochem. Res. 28, 1017-1027
5. Dodart, J. C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 5, 452-457
6. Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Muller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38, 547-554
7. Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (London) 408, 979-982
8. Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (London) 408, 982-985
9. Ujiie, M., Dickstein, D. L., Carlow, D. A., and Jefferies, W. A. (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463-470
10. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102
11. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218
12. Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916-919
13. Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., and LaFerla, F. M. (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321-332
14. Mohajeri, M. H., Kuehnle, K., Li, H., Poirier, R., Tracy, J., and Nitsch, R. M. (2004) Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. FEBS Lett. 562, 16-21
15. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., et al. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421
16. Streit, W. J., Walter, S. A., and Pennell, N. A. (1999) Reactive microgliosis. Prog. Neurobiol. 57, 563-581
17. Nelson, P. T., Soma, L. A., and Lavi, E. (2002) Microglia in diseases of the central nervous system. Ann. Med. 34, 491-500
18. Austyn, J. M., and Gordon, S. (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815
19. Uyama, O., Okamura, N., Yanase, M., Narita, M., Kawabata, K., and Sugita, M. (1988) Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow Metab. 8, 282-284
20. Methia, N., Andre, P., Hafezi-Moghadam, A., Economopoulos, M., Thomas, K. L., and Wagner, D. D. (2001) ApoE deficiency compromises the blood brain barrier especially after injury. Mol. Med. 7, 810-815
21. Blanc, E. M., Toborek, M., Mark, R. J., Hennig, B., and Mattson, M. P. (1997) Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870-1881
22. DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M., and Holtzman, D. M. (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264-2267
23. Dickson, D. W. (2004) Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J. Clin. Invest. 114, 23-27
24. Thomas, T., Thomas, G., McLendon, C., Sutton, T., and Mullan, M. (1996) beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature (London) 380, 168-171
25. Wardlaw, J. M., Sandercock, P. A., Dennis, M. S., and Starr, J. (2003) Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34, 806-812
26. Ueno, M., Sakamoto, H., Liao, Y. J., Onodera, M., Huang, C. L., Miyanaka, H., and Nakagawa, T. (2004) Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem. Cell Biol. 122, 131-137
27. Miyakawa, T., Shimoji, A., Kuramoto, R., and Higuchi, Y. (1982) The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch. B Cell Pathol. 40, 121-129
28. Racke, M. M., Boone, L. I., Hepburn, D. L., Parsadainian, M., Bryan, M. T., Ness, D. K., Piroozi, K. S., Jordan, W. H., Brown, D. D., Hoffman, W. P., et al. (2005) Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. J. Neurosci. 25, 629-636
29. Ferrer, I., Boada Rovira, M., Sanchez Guerra, M. L., Rey, M. J., and Costa-Jussa, F. (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol. 14, 11-20
30. Kawai, M., Kalaria, R. N., Harik, S. I., and Perry, G. (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am. J. Pathol. 137, 1435-1446
31. Lemere, C. A., Spooner, E. T., LaFrancois, J., Malester, B., Mori, C., Leverone, J. F., Matsuoka, Y., Taylor, J. W., DeMattos, R. B., Holtzman, D. M., et al. (2003) Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice. Neurobiol. Dis. 14, 10-18
32. Uchikado, H., Akiyama, H., Kondo, H., Ikeda, K., Tsuchiya, K., Kato, M., Oda, T., Togo, T., Iseki, E., and Kosaka, K. (2004) Activation of vascular endothelial cells and perivascular cells by systemic inflammation - an immunohistochemical study of postmortem human brain tissues. Acta Neuropathol. (Berlin) 107, 341-351
33. Guo, J. T., Yu, J., Grass, D., de Beer, F. C., and Kindy, M. S. (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J. Neurosci. 22, 5900-5909
34. Wong, M. L., Rettori, V., al-Shekhlee, A., Bongiorno, P. B., Canteros, G., McCann, S. M., Gold, P. W., and Licinio, J. (1996) Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 2, 581-584
35. Vagnucci, A. H., Jr., and Li, W. W. (2003) Alzheimer's disease and angiogenesis. Lancet 361, 605-608
36. Suhara, T., Magrane, J., Rosen, K., Christensen, R., Kim, H. S., Zheng, B., McPhie, D. L., Walsh, K., and Querfurth, H. (2003) Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3beta signaling-dependent mechanism. Neurobiol. Aging 24, 437-451
37. Yin, K. J., Lee, J. M., Chen, S. D., Xu, J., and Hsu, C. Y. (2002) Amyloid-beta induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J. Neurosci. 22, 9764-9770
38. Paris, D., Town, T., Mori, T., Parker, T. A., Humphrey, J., and Mullan, M. (2000) Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. Neurobiol. Aging 21, 183-197
39. Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A. M., Stern, D., Kim, K. S., Zlokovic, B., and Kalra, V. K. (2000) beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. 279, C1772-C1781
40. Xu, J., Chen, S., Ku, G., Ahmed, S. H., Xu, J., Chen, H., and Hsu, C. Y. (2001) Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J. Cereb. Blood Flow Metab. 21, 702-710
41. Grammas, P., and Ovase, R. (2001) Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 22, 837-842
42. Tarkowski, E., Issa, R., Sjogren, M., Wallin, A., Blennow, K., Tarkowski, A., and Kumar, P. (2002) Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging 23, 237-243
43. Pogue, A. I., and Lukiw, W. J. (2004) Angiogenic signaling in Alzheimer's disease. NeuroReport 15, 1507-1510
44. Kalaria, R. N., Cohen, D. L., Premkumar, D. R., Nag, S., LaManna, J. C., and Lust, W. D. (1998) Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res. Mol. Brain Res. 62, 101-105
45. Leonardi, A., Gandolfo, C., Caponnetto, C., Arata, L., and Vecchia, R. (1985) The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J. Neurol. Sci. 67, 253-261
46. Hampel, H., Muller-Spahn, F., Berger, C., Haberl, A., Ackenheil, M., and Hock, C. (1995) Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation. Dementia 6, 348-354
47. Mruthinti, S., Buccafusco, J. J., Hill, W. D., Waller, J. L., Jackson, T. W., Zamrini, E. Y., and Schade, R. F. (2004) Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol. Aging 25, 1023-1032
48. Das, P., Howard, V., Loosbrock, N., Dickson, D., Murphy, M. P., and Golde, T. E. (2003) Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice. J. Neurosci. 23, 8532-8538
49. Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H., and Weller, R. O. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 9, 448-452
50. Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., et al. (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61, 46-54